Market & Portfolio Update - January 2024

19 February 2024 by Lifetime

Market & Portfolio Update - January 2024

As we kick off the new year, markets have carried the positive momentum from 2023 into January 2024.

The latest batch of global economic data showed mixed data prints in January, with bond yields fluctuating as expectations shifted over the month. Markets were pricing in a 50% chance of a March interest rate cut following weak data, including the producer price index. However, strong employment and US GDP numbers continued to reflect a resilient US economy. Markets finally gained some clarity following the FOMC meeting at the end of January, where rates were held steady, and Fed Chair Powell pushed back on a March rate cut and indicated they need to see more evidence of inflation falling to the 2% target level sustainably before considering a cut.

New Zealand markets also saw some volatility following the latest headline inflation figures that were released, coming in at 4.7%, down from 5.6% in the September quarter. One notable point from the report was non tradeables inflation – which covers goods and services that do not face foreign competition and is a better indication of domestic demand and supply affecting consumer prices. This came in at 1.1%, ahead of the Reserve Bank forecast of 0.8% for the quarter, and the market’s reaction implied we might need to see rates higher for longer for a sustained decrease back to the 1-3% target zone. 

Global share market sentiment has also been positive, with markets gaining 4.1% in January. Rothschild and Fisher carried on their stellar 2023 performance, returning 6% and 6.2%, respectively. Rothschild was driven by ASML, the leading manufacturer of chip-making equipment, after it returned 19% in January. Fisher’s best-performing stock was Nvidia, which soared 27% in January. Our in-house tactical allocations to the US Communications and Technology sectors also added value, as these sectors were up 7.2% and 5.5% for the month. 

January not only brought sunshine for Kiwis but also the latest round of global companies' earnings. Some notable mentions from reports were that Netflix had 13.1 million net subscribers for the quarter (4 million ahead of forecasts). Novo Nordisk forecasted strong growth in 2024, led by its diabetes and weight loss drug treatments. After an impressive update, Microsoft reported $62 billion in quarterly revenue, with Azure Cloud growth 30% year on year. ASML saw a 30% increase in yearly revenue and orders jump for its Lithography systems, forecasting strong demand for artificial intelligence chips.

preview image - Lifetime Book Club: The Green Mile by Stephen King

Lifetime Book Club: The Green Mile by Stephen King

Sometimes the most powerful stories aren’t the ones that scare us. They’re the ones that move us.

Stephen King might be best known for horror, but The Green Mile is a story of humanity, compassion, and courage in the face of unthinkable circumstances. Set in a 1930s prison, it follows Paul Edgecombe, a death row officer, and John Coffey, a man with extraordinary empathy and an inexplicable gift.

31 October 2025 by Lifetime
preview image - The Growing Divide: Why Private Medical Claims Are Surging in New Zealand

The Growing Divide: Why Private Medical Claims Are Surging in New Zealand

It feels like there is another headline about our public health system being under pressure every week. Long waitlists, staff shortages, and hospitals struggling to keep up. It is no surprise that more Kiwis are turning to private healthcare to get the treatment they need and faster.

28 October 2025 by Emily Wheatley in Health